Skip to main content
Clinical Trials/CTRI/2013/05/003708
CTRI/2013/05/003708
Recruiting
Phase 3

Randomized controlled trial of perioperative versus postoperative chemotherapy in resectable carcinoma stomach - SIOG-STO-1

South Indian Oncology Group0 sites350 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
South Indian Oncology Group
Enrollment
350
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
South Indian Oncology Group

Eligibility Criteria

Inclusion Criteria

  • Histologically proven adenocarcinoma of the stomach or Siewert type 3 adenocarcinoma of the gastroesophageal junction stage T2\-4 Nx or Tx N\+.
  • Resectable disease
  • No distant metastasis, including peritoneal carcinomatosis
  • No gastric outlet obstruction or uncontrolled bleeding
  • CT scan and diagnostic laparoscopy are mandatory
  • No prior therapy for the diagnosed gastric cancer
  • Patient characteristics:
  • Age\- 20 to 69 years
  • ECOG performance status 0\-2
  • Hemopoetic\-

Exclusion Criteria

  • Not pregnant or nursing
  • Fertile patients must use effective contraception
  • No other prior or concurrent neoplasm except adequately treated carcinoma in situ of cervix or basal cell carcinoma of skin
  • No active infection
  • No allergy to protocol drugs
  • No history of significant neurologic or psychiatric disorders
  • No other serious medical condition that would prevent compliance

Outcomes

Primary Outcomes

Not specified

Similar Trials